Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zhouguang Hui MD"'
Autor:
Jian Guo BS, Meng Zhu BS, Weijin Zeng BS, He Wang MS, Songbing Qin MD, Zhibin Li, Yu Tang PhD, Binbin Ying MD, Jiugao Sang, Ming Ji PhD, Kuo Meng PhD, Zhouguang Hui MD, Jianyang Wang MD, Juying Zhou MD, Yin Zhou PhD, Jian Huan MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Purpose: This study aims to develop a data-collecting package ExpressMLC and investigate the applicability of MapCHECK2 for multileaf collimator (MLC) modeling and commissioning for complex radiation treatment plans. Materials and methods: The MLC mo
Externí odkaz:
https://doaj.org/article/886a5e955801456ca71b9e30fb07eaa2
Autor:
Xu Yang MD, Yu Men MD, Jianyang Wang MD, Jingjing Kang MD, Xin Sun MD, Maoyuan Zhao MD, Shuang Sun MD, Meng Yuan MD, Yongxing Bao MD, Zeliang Ma MM, Guiqi Wang MD, Zhouguang Hui MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Objective: To evaluate the safety and efficacy of additional radiotherapy after endoscopic resection (ER) for stage I esophageal carcinoma (EC) with high-risk factors. Materials and methods: Patients with stage cT1N0M0 EC who underwent ER and additio
Externí odkaz:
https://doaj.org/article/3b062a2cc8df4607a309ac5d0de72f18
Autor:
Jianrui Ji, MD, Yunsong Liu, MD, Yongxing Bao, MD, Yu Men, MD, Jun Wang, MD, Zhouguang Hui, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 7, Pp 101522- (2024)
Purpose: Initial studies investigating the combination of local and systemic treatments in advanced esophageal cancer (EC) have conflicting conclusions regarding survival benefits. The objective of this systematic review and meta-analysis is to asses
Externí odkaz:
https://doaj.org/article/836b78a2ef22450d8abab95a83d9b14f
Autor:
Zeliang Ma, MD, Yunsong Liu, MD, Yongxing Bao, MD, Meng Yuan, MD, Xu Yang, MD, Yu Men, MD, Jianyang Wang, MD, Lei Deng, MD, Yirui Zhai, MD, Nan Bi, MD, Luhua Wang, MD, Zhouguang Hui, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101213- (2023)
Purpose: Cardiopulmonary toxic effects may reduce the efficacy of postoperative radiation therapy (PORT) in patients with non-small cell lung cancer (NSCLC). However, few studies have examined whether the heart and lung doses affect overall survival
Externí odkaz:
https://doaj.org/article/7d6457e2625d48eab79fc4d5abc400b7